Ezlopitant
Ezlopitant (CJ-11,974) is an NK1 receptor antagonist. It has antiemetic and antinociceptive effects. Pfizer was developing ezlopitant for the treatment of irritable bowel syndrome but it appears to have been discontinued.
primaryTopic
Ezlopitant
Ezlopitant (CJ-11,974) is an NK1 receptor antagonist. It has antiemetic and antinociceptive effects. Pfizer was developing ezlopitant for the treatment of irritable bowel syndrome but it appears to have been discontinued.
has abstract
Ezlopitant (CJ-11,974) is an N ...... ars to have been discontinued.
@en
Ezlopitant ist eine chemische ...... ant ein Neurokinin-Antagonist.
@de
ATC prefix
CAS number
147116-64-1
FDA UNII code
3L098A8MPY
IUPAC name
(2S,3S)-2-benzhydryl-N-[(5-isopropyl-2-methoxy-phenyl)methyl]quinuclidin-3-amine
@en
PubChem
thumbnail
Wikipage page ID
26,358,555
Wikipage revision ID
722,248,874
ChEMBL
ChemSpiderID
IUPHAR ligand
legal status
molecular weight
routes of administration
hypernym
comment
Ezlopitant (CJ-11,974) is an N ...... ars to have been discontinued.
@en
Ezlopitant ist eine chemische ...... ant ein Neurokinin-Antagonist.
@de
label
Ezlopitant
@de
Ezlopitant
@en
